Actively Recruiting

Phase Not Applicable
Age: 25Years +
FEMALE
NCT05413798

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa

Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-06-29

300

Participants Needed

1

Research Sites

168 weeks

Total Duration

On this page

Sponsors

U

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women. Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that lead to cervical precancer and, eventually, cervical cancer if untreated. However, urine HPV testing has not been well validated low- and middle-income country settings, with no data available to guide its use in HIV-infected women.

CONDITIONS

Official Title

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa

Who Can Participate

Age: 25Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed HIV-1 infection
  • Age 25 years and older
  • Willing and able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Pregnant or planning to become pregnant within 90 days of enrollment
  • Screened for cervical cancer within the preceding year
  • Have an active sexually transmitted infection (may participate once treated)
  • Surgically absent cervix
  • History of cervical cancer
  • Previously vaccinated against HPV

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital

Westdene, Johannesburg, South Africa, 2092

Actively Recruiting

Loading map...

Research Team

C

Cheryl Hendrickson

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here